Journal of Clinical Endocrinology & Metabolism, Vol 67, 793-800, Copyright © 1988 by Endocrine Society

ARTICLES

Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism

V Padmanabhan, RP Kelch, J Sonstein, CM Foster and IZ Beitins
Department of Pediatrics, University of Michigan, Ann Arbor 48109.

To test the hypothesis that exogenous pulsatile administration of GnRH will increase serum bioactive FSH (bFSH) levels, we studied four boys with suspected idiopathic hypogonadotropic hypogonadism (IHH). These boys presumably secreted relatively little GnRH. By virtue of their low baseline serum gonadotropin levels yet responsive pituitary gonadotrophs, these boys with IHH proved to be an excellent clinical model to test this hypothesis. Administration of GnRH (0.025 microgram/kg.dose) iv at 1- or 2-h intervals for 3-5 days resulted in an increase in serum bFSH after 91% of the GnRH doses. Serum immunoreactive FSH (iFSH) and LH (iLH) levels increased after 42% and 64% of the GnRH doses, respectively. Ninety percent of the iLH responses were concordant with bFSH responses, but only 33% of the iLH responses were concordant with iFSH responses. The serum bFSH responses occurred consistently within 20 min after GnRH administration and resulted in an increased serum bioactive to immunoreactive FSH ratio. By 60 min, serum bFSH levels had returned to preinjection levels. Serum testosterone and estradiol levels did not change during the period of GnRH administration in three of the four boys. We conclude that pulsatile, low dose iv GnRH administration in boys with IHH elicits significant serum bFSH increases by 20 min; the newly secreted FSH is preferentially enriched with increased in vitro FSH bioactivity, and it is rapidly cleared from serum (60 min). Therefore, serum bFSH measurements may provide a sensitive index of GnRH effects on the gonadotrophs.

This article has been cited by other articles:

				V. Padmanabhan, M. B. Brown, G. E. Dahl, N. P. Evans, F. J. Karsch, D. T. Mauger, J. D. Neill, and J. Van Cleeff Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion: III. Is There a Gonadotropin-Releasing Hormone-Independent Component of Episodic FSH Secretion in Ovariectomized and Luteal Phase Ewes? Endocrinology, April 1, 2003; 144(4): 1380 - 1392. [Abstract] [Full Text] [PDF]

				C. R. West, N. E. Carlson, J. S. Lee, A. S. McNeilly, T. P. Sharma, W. Ye, and V. Padmanabhan Acidic Mix of FSH Isoforms Are Better Facilitators of Ovarian Follicular Maturation and E2 Production than the Less Acidic Endocrinology, January 1, 2002; 143(1): 107 - 116. [Abstract] [Full Text] [PDF]

				V. Padmanabhan, K. McFadden, D. T. Mauger, F. J. Karsch, and A. R. Midgley Jr. Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion. I. Direct Evidence for Separate Episodic and Basal Components of FSH Secretion Endocrinology, January 1, 1997; 138(1): 424 - 432. [Abstract] [Full Text] [PDF]